03 - Navigating the Future of Pharmacy Benefit Costs: Trends, GLP-1, and Gene Therapy
This session will feature an in-depth analysis of pharmacy cost pressures with a focus on the impact of GLP-1 and Gene Therapy.
Speakers:
Donna C. Novak
NovaRest Actuarial Consulting
Kali Schweitzer PharmD
Milliman Inc.
Mr. Ron Ogborne
Mercer
Ms. Sarah Suzanne Hellems
Optum Pharmacy Advisory Services